Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.37
Delayed Data
As of Mar 31
 -0.09 / -1.21%
Today’s Change
3.79
Today|||52-Week Range
9.35
+37.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-27.4M-32.8M-67.3M-65.8M
 
 
 
 
 
Depreciation2.0K10.0K14.0K11.0K
 
 
 
 
 
Total Other Cash Flow15.7M16.0M28.9M13.5M
 
 
 
 
 
Funds From Operations-11.7M-16.8M-38.4M-52.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-5.3M-2.1M-15.6M-14.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-6.4M-14.7M-22.8M-37.8M
 
 
 
 
 
 
InvestingCapital Expenditures-41.0K-49.0K-31.0K--
 
 
 
 
Fixed Asset Disposal0.000.000.001.0K
 
 
Net Cash Flow Investing-41.0K-49.0K-31.0K1.0K
 
 
 
 
 
 
FinancingShort Term Borrowings240.0K--0.000.00
 
 
Long Term Borrowings3.0M10.0M13.2M-2.3M
 
 
 
 
 
Long Term Debt Reduction-551.0K-849.0K-2.2M-2.3M
 
 
 
 
 
Net Proceeds Stock Sale3.9M5.5M19.2M53.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing6.6M14.6M30.1M49.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-104.0K3.0K-40.0K0.00
 
 
 
 
 
Net Change In Cash192.0K-132.0K7.4M11.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account